Requires pharmacies to provide certain information regarding insulin manufacturer assistance programs.
Requires pharmacies to provide certain information regarding insulin manufacturer assistance programs.
Relating to information provided by health care providers and hospitals to certain patients regarding pharmaceutical manufacturer patient assistance programs for insulin.
Relating to information provided by health care providers and hospitals to certain patients regarding pharmaceutical manufacturer patient assistance programs for insulin.
Provides that purchase of insulin is not subject to deductible; requires health insurers to limit copayments and coinsurance for insulin; requires insulin manufacturers to submit report to Commissioner of Banking and Insurance.
Provides that purchase of insulin is not subject to deductible; requires health insurers to limit copayments and coinsurance for insulin; requires insulin manufacturers to submit report to Commissioner of Banking and Insurance.
Requires drug manufacturers to provide information regarding prescription drug prices (EN NO IMPACT See Note)
Establishes insulin assistance program.
Establishes insulin assistance program.
Requires DOH to maintain emergency stockpile of insulin and authorizes dispensing of emergency supply of insulin to certain patients.